The UAE cardiovascular devices market size was estimated at USD 262.53 million in 2025 to reach nearly USD 463.54 million by 2035, and is expanding at A CAGR of 5.85% from 2026 to 2035. The market is mainly driven by the high rates of cardiovascular diseases, an aging population, and important government efforts aimed at early detection and improved healthcare systems.

UAE Cardiovascular Device Market Statical Scope

This market is vital because cardiovascular diseases (CVDs) cause many deaths in the area, and the government is strategically working to make the UAE a top global medical tourism destination. The strong use of advanced technologies like AI and robotics, along with significant investments in infrastructure, make it an important market. Dubai and Abu Dhabi are becoming key centers for cardiac care, drawing in international patients and increasing the demand for high-quality, modern interventional equipment.

Cardiovascular diseases are the top cause of death, leading to the need for advanced solutions such as minimally invasive transcatheter procedures, pacemakers, and stents to enhance patient outcomes. The market is quickly adopting AI-driven diagnostic tools, remote monitoring, and more AI and robotics for greater precision in procedures. Rising healthcare spending, high GDP per capita, and supportive regulations for medical device companies are driving market growth. The UAE serves as a crucial link connecting global manufacturers from Europe, the US, and Asia to the wider GCC market.

UAE Cardiovascular Devices Market, By Product, 2025 (%)

• Diagnostic & Monitoring - The Diagnostic & Monitoring segment, with a share of 41%, plays a vital role in the market due to the increasing prevalence of cardiovascular diseases such as obesity, a sedentary lifestyle, and an aging population, which allows for early detection to avert fatalities.
• Surgical Devices - The surgical devices segment, with a share of 59%, is dominant in the market because of the growing incidence of heart diseases, a strong demand for minimally invasive procedures like cardiac catheterization, and advancements in robotic-assisted surgeries.

UAE Cardiovascular Devices Market, By Distribution Channel, 2025 (%)

• Online - The online segment, with a share of 23%, is important in the market due to the swift adoption of digital procurement platforms, which offer convenience, competitive pricing, and quicker delivery, with online sales expected to grow the fastest.
• Offline - The offline segment, with a share of 77%, is crucial to the market because face-to-face negotiations are necessary for high-value hospital procurement, hands-on training is required for advanced technology, and there are strict regulatory, logistical, and after-sales service requirements.

UAE Cardiovascular Devices Market, By End-use, 2025 (%)

• Hospitals - The hospital segment, with a share of 62%, is the leading force in the market, as they serve as primary centers for high-acuity, complex procedures. This is critical because hospitals have advanced surgical infrastructure, specialized cardiac catheterization labs, and trained professionals needed for intensive procedures.
• Ambulatory Surgical Centers - The Ambulatory Surgical Centers (ASC) segment, with a share of 16%, is quickly growing in the Market because they provide cost-effective, same-day alternatives to hospitals for minimally invasive procedures, catering to a trend towards outpatient care, shorter recovery times, and lower operational costs.
• Diagnostic Centers - The Diagnostic Centers segment, with a share of 14%, is a key growth driver in the Market as it provides high-volume, accessible, and advanced screening services that facilitate early detection of cardiac conditions.
• Others – Others segment, with a 8% share, contributes minimally.

Top Companies in the UAE Cardiovascular Devices Market

• Abbott
• GE HealthCare
• Edwards Lifesciences Corporation
• Siemens Healthineers AG
• Canon Medical Systems
• B. Braun SE
• LivaNova, Inc.
• Cardinal Health
• Medtronic
• Boston Scientific Corporation
• W. L. Gore & Associates, Inc.
• BIOTRONIK SE & Co. KG

Segments Covered in the Report

By Product

• Diagnostic & Monitoring
• Surgical Devices

By Distribution Channel

• Online
• Offline

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Others